Idexx Laboratories | IDXX - Sales Revenues

Stock Price
560.15
Daily Change
7.38 1.34%
Monthly
-0.14%
Yearly
11.68%
Q2 Forecast
518.16

Idexx Laboratories reported $1.14B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Abbott USD 11.16B 300M Mar/2026
Accuray USD 116.17M 14.63M Dec/2024
Align Technology USD 1.04B 10M Mar/2026
AngioDynamics USD 79.43M 3.72M Sep/2025
Dentsply International USD 880M 81M Mar/2026
Dexcom USD 1.19B 70M Mar/2026
Edwards Lifesciences USD 1.65B 80M Mar/2026
Fujifilm JPY 927.25B 69.9B Mar/2026
Globus Medical USD 759.85M 66.55M Mar/2026
Henry Schein USD 3.37B 30M Mar/2026
Idexx Laboratories USD 1.14B 50M Mar/2026
Inogen USD 74.93M 504K Sep/2024
Insulet USD 761.7M 22.1M Mar/2026
Integra LifeSciences USD 391.9M 43M Mar/2026
Intuitive Surgical USD 2.77B 100M Mar/2026
Masimo USD 403.6M 8.9M Mar/2026
Neogen USD 211.2M 13.49M Dec/2025
Orthofix International USD 219.91M 14.28M Dec/2025
Phibro Animal Health USD 373.91M 10.02M Dec/2025
ResMed USD 1.4B 0 Mar/2026
Roche Holding CHF 15.65B 274.5M Dec/2025
Steris USD 1.59B 90M Mar/2026
Tandem Diabetes Care USD 247.22M 43.18M Mar/2026
Teleflex USD 548.3M 20.68M Mar/2026
Thermo Fisher Scientific USD 11.01B 1.2B Mar/2026
Zoetis USD 2.3B 100M Mar/2026